UVD robots to help Covid response in European hospitals

By Leila Hawkins
UVD robots to be deployed to disinfect operating rooms in European hospitals...

UVD disinfectant robots are set to be deployed in European hospitals after the European Commission ordered 200 to help fight the COVID-19 pandemic, as well as other infections. 

Developed by UVD Robots and Blue Ocean Robotics, the autonomous robots use ultraviolet light to kill viruses and bacteria on surfaces.      

The robots are part of Ecolab’s Premium Operating Room Program, designed to help reduce the risk and burden of healthcare-associated infections (HCAIs). Fully mobile and autonomous, they have been designed to help save time - as they don’t require repositioning and allow healthcare professionals to dedicate their time to other tasks. 

COVID-19 has created lengthy waiting lists for elective surgeries, as the intensive cleaning of operating rooms to prevent infection has added a substantial amount of time between surgeries. 

In the UK, at the end of November 2020, 192 169 patients had been waiting more than 52 weeks for planned surgery, whereas in the same month in 2019 the number was just 1398. Researchers believe it will take 45 weeks to clear the backlog created during the first wave alone.

“The robots are designed to drive improvements in operating theatre availability and general infection prevention advancement” said Howard Wilkinson, Area Vice President for Ecolab Healthcare in Northern Europe & Benelux.

“Using technology from UVD Robots integrated into Ecolab Programs, hospitals will have access to cleaning compliance improvement coupled with automated robots with state-of-the-art UV-C disinfection technology.” 

Share

Featured Articles

UnitedHealth CEO Admits Hack hit Third of US Citizens' Data

UnitedHealth Group CEO Andrew Witty tells stunned US congressional hearing Change Healthcare cyberattack affects third of the US population

Why Sanofi Leads the way on Healthcare Sustainability

How French multinational Sanofi is ensuring delivery of essential medical supplies while being ESG-compliant

Philips Q1 Results hit by $1.1bn Respironics Settlement

As Royal Philips reports Q1 2024 results we profile the Netherlands-based healthcare technology company, who made the switch from consumer electronics

Vaccine Breakthrough on Antibiotics Resistant Diseases

Medical Devices & Pharma

Oracle Fusion Cloud Update Boost for Patients

Technology & AI

WHO Tightens air Quality Guidelines as Pollution Kills 7mn

Sustainability